Reduced spectral resolution ability limits speech recognition in cochlear implant (CI) listeners. While several studies have examined the association between spectral resolution and speech perception, uncertainties persist regarding the strength of this link and related methodological and clinical factors. This review synthesizes prior findings on this relationship in postlingually deafened adult CI listeners using psychophysical measures of spectral resolution, evaluated based on four criteria: (1) whether they consider the categorization nature of speech recognition task, (2) whether they account for modulation frequency within and across spectral channels while capturing essential spectral modulations in speech, (3) whether they assess spectral resolution globally or at a channel-specific level, and (4) their relative time efficiency for clinical application. Many studies report a significant association, with some measures—such as test of spectral ripple discrimination threshold and its modified versions—demonstrating superior predictive capacity, yet no single measure meets all criteria. Our review highlights the critical role of methodological factors and calls for more refined, effective, and channel-specific assessment techniques that better capture the link between spectral resolution and speech perception in CI listeners. These approaches may improve clinical CI programming by addressing poorly functioning electrodes and enhancing perceptual outcomes in postlingually deafened adult CI listeners.

The authors have declared no competing interest.

We gratefully acknowledge the support provided by startup funds from the University of South Carolina to M.A.; a Presidential Fellowship awarded to S.A.; the Magellan Scholar Grant, awarded to R.F. and K.M., from the Office of the Vice President for Research at USC; and the Honors College Research Grant, awarded to R.F. and K.M. at USC, as well as the assistance of the USC Institute for Mind and Brain in supporting this work.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors